Mingzhao Xing

  • Mingzhao Xing, MD, Ph D, is Dean of the School of Medicine, Southern University of Science and Technology in Shenzhen City, China and tenured Professor of Medicine, Oncology, and Pathology at the Johns Hopkins School of Medicine. He is an American board-certified endocrinologist and internist. His research on thyroid cancer results in >170 publications in Lancet, JAMA, J Clin Oncol, JAMA Oncol, J Clin Invest, Nat Commun, Nat Rev Cancer, etc, with nearly 17,000 citations. He holds eight USA patents on BRAF V600E and TERT promoter mutations and related discoveries in thyroid cancer. He received the 2006 Maryland Innovator Award, the 2013 British Endocrine Society’s Endocrine-Related Cancer Research Award, the 2014 Chinese Endocrine Society’s Zhu Xianyi Award, the 2016 American Thyroid Association (ATA)’s Paul Starr Award, and the 2017 Johns Hopkins’ Paul W Ladenson Thyroid Award. He served ATA’s Research Committee Chair, Annual Meeting Program Scientific Chair and Associate Editor of the journal Thyroid.


     

 

Leave a Reply